Published in Front Immunol on October 21, 2014
Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med (2015) 1.04
Diversity of the CD4 T Cell Alloresponse: The Short and the Long of It. Cell Rep (2016) 0.78
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
Pharmacological Tie2 activation in kidney transplantation. World J Transplant (2016) 0.75
Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med (2011) 6.72
Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Evolving functions of endothelial cells in inflammation. Nat Rev Immunol (2007) 4.94
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med (2005) 4.84
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
RENAL HOMOGRAFTS IN PATIENTS WITH MAJOR DONOR-RECIPIENT BLOOD GROUP INCOMPATIBILITIES. Surgery (1964) 2.16
Humoral theory of transplantation. Am J Transplant (2003) 2.04
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
Antibody-mediated organ-allograft rejection. Nat Rev Immunol (2005) 1.99
Transplantation 50 years later--progress, challenges, and promises. N Engl J Med (2004) 1.86
Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med (2002) 1.84
Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol (1987) 1.73
ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation (2009) 1.71
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61
Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant (2007) 1.60
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation (2002) 1.58
Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts. Transplantation (2010) 1.50
Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A (2009) 1.47
Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance. J Exp Med (2011) 1.43
Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol (1991) 1.42
Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci U S A (2007) 1.39
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant (2011) 1.37
Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol (2008) 1.33
Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant (2005) 1.32
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol (2008) 1.31
Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. J Immunol (1994) 1.29
Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol (1998) 1.26
Effect of antibodies on endothelium. Am J Transplant (2009) 1.23
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. Am J Transplant (2013) 1.23
Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation (2010) 1.15
Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys--correlation with intragraft events. Transplantation (1993) 1.12
Can graft endothelial cells initiate a host anti-graft immune response? Transplantation (1996) 1.12
Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A (2011) 1.10
Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol (1999) 1.10
Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int (2001) 1.10
Role of anti-vimentin antibodies in allograft rejection. Hum Immunol (2013) 1.09
Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol (1991) 1.07
HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration. Sci Signal (2010) 1.06
Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation (2002) 1.06
Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation (2009) 1.05
Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol (2012) 1.05
Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc (2005) 1.04
Role of IFNgamma in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells. Am J Transplant (2007) 1.04
ABO-incompatibility in solid organ transplantation. Transfus Med (2001) 1.04
Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol (1997) 1.03
Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor. J Leukoc Biol (2007) 1.03
Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression. Am J Transplant (2011) 1.02
Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant (2001) 1.00
Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol (2004) 0.99
ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc (1987) 0.98
Endothelial cells as antigen-presenting cells: role in human transplant rejection. Cell Mol Life Sci (1998) 0.98
Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant (2003) 0.98
Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol (2002) 0.97
ABO-incompatible solid-organ transplantation. Am J Clin Pathol (2006) 0.96
Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation (2006) 0.96
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. J Clin Invest (2013) 0.96
Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation (2004) 0.94
Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J Immunol (2011) 0.94
Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J Immunol (1997) 0.94
ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transplant (2010) 0.93
Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA. J Immunol (1999) 0.91
Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol (2011) 0.91
Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol (2010) 0.91
Characterization of the endothelial cell cytoskeleton following HLA class I ligation. PLoS One (2012) 0.91
An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol (1998) 0.90
Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant (2009) 0.89
Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation (2011) 0.89
Accelerated arteriosclerosis: a form of transplant arteriopathy. Curr Opin Organ Transplant (2010) 0.88
Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation (2005) 0.86
Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells. J Immunol (1992) 0.86
Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant (2009) 0.85
Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol (2011) 0.85
Endothelial cells as targets of allograft rejection. Transplantation (2006) 0.85
Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol (2008) 0.84
Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathway. Transpl Immunol (1994) 0.84
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2. J Exp Med (2014) 0.84
Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient. Pediatr Transplant (2010) 0.82
Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation (1981) 0.82
Antibodies to kidney endothelial cells contribute to a "leaky" glomerular barrier in patients with chronic kidney diseases. Am J Physiol Renal Physiol (2011) 0.82
Serotyping for homotransplantation. XXII. Specificity of cytotoxic antibodies developing after renal transplantation. Br Med J (1969) 0.82
Th17 cells induce a distinct graft rejection response that does not require IL-17A. Am J Transplant (2012) 0.82
Profiling posttransplant circulating antibodies in kidney transplantation using donor endothelial cells. Transplantation (2012) 0.80
Clinical significance of anti-endothelial cell antibody in renal transplant recipients. Korean J Intern Med (2001) 0.80
The indirect alloimmune response causes microvascular endothelial dysfunction-a possible role for alloantibody. Transplantation (2010) 0.78
Accommodation: does it apply to human leukocyte antigens? Transplantation (2012) 0.78
Detection of alloantibodies against non-HLA antigens in kidney transplantation by flow cytometry. Clin Transplant (2000) 0.77
Targeting B cells in sensitized kidney transplant patients: state of the art and future perspectives. Curr Opin Organ Transplant (2010) 0.77
Hyperacute rejection of living related kidney graft caused by IgG endothelial specific antibodies with a negative monocyte cross-match. Ann Transplant (2002) 0.77
A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells. Tissue Antigens (2010) 0.76
Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients. Hum Immunol (2014) 0.76
Non-human leukocyte antigen antibodies reactive with endothelial cells could be involved in early loss of renal allografts. Transplant Proc (2011) 0.76
Detection and localization of non-HLA-ABC antigenic sites relevant to kidney rejection on endothelial cells. J Immunol Methods (2001) 0.76
Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation (1998) 0.75